Glycosaminoglycan Scores as Early Detection Biomarkers in Bladder Urothelial Carcinoma

CompletedOBSERVATIONAL
Enrollment

106

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions
Bladder Cancer
Interventions
DIAGNOSTIC_TEST

Free glycosaminoglycan profiling

Free glycosaminoglycan profiling (GAGome) analysis was performed at a single blinded central laboratory using commercial kits wherein the concentration (in µg/mL) of 17 chondroitin sulfate (CS), heparan sulfate (HS), hyaluronic acid (HA) disaccharides were detected and quantified using a UHPLC-MS/MS system.

Trial Locations (1)

Unknown

Department of Urology, Institute of Clinical Science, Sahlgrenska Academy, University of Gothenburg, Gothenburg

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Göteborg University

OTHER

lead

Jens Nielsen

OTHER

NCT05799456 - Glycosaminoglycan Scores as Early Detection Biomarkers in Bladder Urothelial Carcinoma | Biotech Hunter | Biotech Hunter